QuintilesIMS leading Big Pharma firms in oncology collaboration
The new collaborative initiative will be led by QuintilesIMS, with founding partners including Bristol-Myers Squibb, Eli Lilly and Company, Merck KGaA, and Pfizer.
Archives for November 22, 2016
Cel-Sci responds to US FDA clinical hold on Multikine study
Cel-Sci has responded to the partial clinical hold imposed on a Phase III trial of its candidate head and neck cancer cell therapy Multikine in September.
Sanofi Pasteur confirms plant problems prompted TheraCys decision
Sanofi Pasteur has confirmed the decision to stop making the bladder cancer drug TheraCys was prompted by long running problems at the Toronto manufacturing plant where it is made.
US FDA calls Wockhardt efforts to fix Wrexham plant 'inadequate'
Efforts by Wockhardt to fix violations at drug plant in Wrexham, Wales are inadequate according to the US FDA which detailed its concerns in a warning letter this week.
update
US FDA lifts clinical hold after Aduro modifies listeria-based therapy trials
The US FDA has cleared Aduro Biotech to recruit for trials of its listeria-based immunotherapies after the firm modified protocols to reduce the risk of subjects developing listeriosis.
Swallowing Stars: MIT spin-out invents gastric device which solves problem of daily dosing
Lyndra Inc. has developed a star shaped gastric device which claims to solve the problem of delivering drugs with short half-lives.
Clinical Ink updates patient engagement app
Clinical Ink has announced the latest release of SureSource Engage, which enables clinical trial sponsors and contract research organizations (CROs) to increase patient adherence.